1. Home
  2. MMI vs RLAY Comparison

MMI vs RLAY Comparison

Compare MMI & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MMI

Marcus & Millichap Inc.

HOLD

Current Price

$29.58

Market Cap

1.2B

Sector

Finance

ML Signal

HOLD

Logo Relay Therapeutics Inc.

RLAY

Relay Therapeutics Inc.

HOLD

Current Price

$7.84

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MMI
RLAY
Founded
1971
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.0B
IPO Year
2013
2020

Fundamental Metrics

Financial Performance
Metric
MMI
RLAY
Price
$29.58
$7.84
Analyst Decision
Sell
Strong Buy
Analyst Count
2
9
Target Price
$29.00
$16.00
AVG Volume (30 Days)
189.9K
2.2M
Earning Date
11-07-2025
11-06-2025
Dividend Yield
1.69%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$751,284,000.00
$8,355,000.00
Revenue This Year
$11.94
$20.47
Revenue Next Year
$15.59
N/A
P/E Ratio
N/A
N/A
Revenue Growth
20.74
N/A
52 Week Low
$27.35
$1.78
52 Week High
$42.53
$8.36

Technical Indicators

Market Signals
Indicator
MMI
RLAY
Relative Strength Index (RSI) 51.09 62.89
Support Level $28.74 $7.23
Resistance Level $30.30 $8.36
Average True Range (ATR) 0.76 0.52
MACD 0.03 0.07
Stochastic Oscillator 62.33 78.88

Price Performance

Historical Comparison
MMI
RLAY

About MMI Marcus & Millichap Inc.

Marcus & Millichap Inc is a national brokerage firm specializing in commercial real estate investment sales, financing, research, and advisory services. The company offers three primary services to its clients: commercial real estate investment brokerage, financing, and ancillary services, including other research, advisory, and consulting services. The company generates revenues by collecting fees on the sale and financing of commercial properties. These fees consist of commissions collected upon the sale of a property and fees collected from the placement of loans.

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).

Share on Social Networks: